Clinical trial
Translation and Validation of the PASS Test for Gastro-esophageal Reflux Disease (GERD) Patients With Partial Response to PPI in Chinese Population: PASS-HK
NCT02437682 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Translation and Validation of the PASS Test for Gastro-esophageal Reflux Disease (GERD) Patients With Partial Response to PPI in Chinese Population: PASS-HK
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 11, 2017
- Completion date
- December 31, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastro-esophageal reflux disease